Back to Search
YOLANTA KRUSZYNSKA, MD, MRCP, PHD
MD, MRCP, PHD
Endocrinology, Diabetes & Metabolism Physician
NPI: 1447232996IndividualAccepts Medicare
Specialties, Licenses & Credentials
Endocrinology, Diabetes & Metabolism PhysicianPrimary
Internal Medicine — Endocrinology, Diabetes & Metabolism
Code: 207RE0101X
A65949(CA)
Education
OTHER
Class of 1979
Research & Publications (8)
Effect of obesity on susceptibility to fatty acid-induced peripheral tissue insulin resistance.
PMID 12601639·Metabolism·2003
8-other
Fatty acid-induced insulin resistance: decreased muscle PI3K activation but unchanged Akt phosphorylation.
PMID 11788651·J Clin Endocrinol Metab·2002
8-other
Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.
PMID 10871202·Diabetes·2000
8-other
The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects.
PMID 12351435·Diabetes·2002
3-trial
Decreased susceptibility to fatty acid-induced peripheral tissue insulin resistance in women.
PMID 11375335·Diabetes·2001
8-other
Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects.
PMID 10857970·Diabetes Care·2000
3-trial
Lack of effect of a physiological elevation of plasma non-esterified fatty acid levels on insulin secretion.
PMID 10804328·Diabetes Metab·2000
3-trial
Effects of insulin on prenylation as a mechanism of potentially detrimental influence of hyperinsulinemia.
PMID 10746633·Endocrinology·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1000 PAJARO ST STE B
SALINAS, CA 93901 - Phone
- (831) 455-8450
Quick Facts
- NPI
- 1447232996
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 47
- Publications
- 8
Are you this provider?
Claim Your Profile